ClinicalTrials.govpublic full text
Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia
leukemia, lymphocytic, chronic, lmb-2, chronic lymphocytic leukemia, cll, immunotoxin, oncology, lymphocytes, hematological disease, monoclonal antibody, neutralizing antibodies
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 861774
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.